The main drawbacks of DNA pronuclear microinjection are associated with the random transgene integration. Insertion position could have some drastic effects on the outcome of the project by :
Modifying the pattern and the level of expression of the transgene
Silencing the transgene expression
Disregulating other genes expression due to transgene integration site
We have developed a technology aimed at solving main drawbacks of DNA pronuclear microinjection by providing a high number of founders with predefined characteristics. This new technology, allowing a first in vitro pre-selection of founder characteristics, secures :
Transgene integrity- avoiding generation of transgenic animals displaying truncated transgene
Transgene copy number- allowing the selection of low, medium or high copy number founders based on scientist's requirements
Orange curve : Classical DNA Transgenesis
Average number of founders obtained by Classical DNA Transgenesis per experiment
Green curve : "Safe DNA Transgenesis"
Average number of founders obtained by
"Safe DNA Transgenesis" per experiment
This could be overcome by analysing a high number of founders allowing to bypass the position effect and to have statistical results correlated to transgene expression.
The number of founders generated by DNA pronuclear microinjection can not be predicted, since the efficiency of this technology ranks from 0% to 10%, based on literatures and personal communication.
Red curve in the figure presented in the central panel represents the average number of founders generated per experiment using classical DNA Tranegenesis.
The average number of founders obtained by using this technology ranks from 0 and 4.
60 to 70% of experiments resulted in a low number of founders (<3), therefore requiring additional experiments to achieve a sufficient number of founders, for relevant in vivo analysis.
Moreover, this unpredictable information is known at the very end of the project, when the animals are genotyped.
This strongly impacts project development timelines and costs.
On average, this novel technology allows the generation of 10 to 30 lines, even if in general scientists first focus on 4 to 7 lines displaying different integration sites and different copy numbers for a first analysis.
Green curve in the figure presented in the central panel represent the average number of founders generated per experiment using : "Safe DNA Transgenesis". Based on our experience using "Safe DNA Transgenesis", the average number of lines that can be developed in one experiment ranks from 10 to 30.
This approach allows generation of high number of founders in a single shot experiment, therefore securing the project issue (sufficient number of founders for relevant in vivo studies) and allowing shorter development times and lower development costs.
Dr. Krejci from CNRS, France
"Powerful and reliable, "Safe DNA transgenesis" permitted the generation of many founders displaying pre-selected characteristics. I would strongly recommend this technology to scientists with high security demands.".
Dr. Boccaccio from Institute of Cancer Research and Treatment, Italy
"I have never witnessed such proactive behavior with customers. genOway truly understands our challenges and is equipped width cutting-edge technologies such as "safe DNA transgenesis" that fulfil our expectations".